Our Group’s strong industrial roots allow us to offer a wide range of products and services. We synthesize active ingredients and develop new formulations that are effective, sustainable and innovative.
Our industrial processes allow us to make certified quality products to satisfy the highest international standards. Sipcam Oxon is focusing its R&D efforts on the development of sustainable biological solutions and handling the increasing demand to limit and reduce chemicals in agriculture. This is being achieved through the development of projects aimed at improve the efficiency of products, for example introducing innovative formulations and delivery systems.
We develop innovative synthesis processes, more efficient and resulting in a high level of purity of active substances.
For most of Sipcam Oxon’s projects, the Chemical Process R&D team provides good intellectual and technical analysis, thanks to its extensive expertise in organic and analytical chemistry.
Our team focuses on transforming chemistry routes into approaches that are commercially viable. High standards are followed during the initial route design, scouting and early process optimisation work, minimising the risks associated with the scale-up of chemistry routes and developing projects that are efficient, safe, scalable and environmentally friendly.
We continue to invest in additional analytical capability to support the growing synthetic capacity, allowing the Chemical Process R&D division to undertake more projects and reduce the time to develop processes and supply products.
We start by defining the product (formulation and active substance) that will be commercialised in a particular geographic area based on technical and market evaluations.
We develop innovative formulations aiming to improve:
The formulation team focuses on creating innovative formulations of all types of agrochemical compounds and biostimulants.
The team prepares different prototypes, each of which is subject to in-vitro and/or field testing and then selected based on cost/benefit analysis, which takes into account the eligibility for registration purposes.
We continue investing in new labs, qualified researchers and equipment to support the growing formulation capacity, allowing the formulation R&D division to facilitate further work and bring projects to market most effectively.
Our Regulatory activity is centralized. After the preliminary risk assessment to evaluate the possibility of meeting the criteria, the team handles field testing of new products and the preparation of dossiers for product registration.
Sipcam Oxon actively collaborate with prestigious universities and research institutes in Italy, Spain, Sweden and Israel.